Fidelity International’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505K | Sell |
4,018
-111
| -3% | -$14K | ﹤0.01% | 792 |
|
|
2025
Q1 | $457K | Sell |
4,129
-10,288
| -71% | -$1.14M | ﹤0.01% | 793 |
|
|
2024
Q4 | $1.97M | Buy |
14,417
+2,452
| +20% | +$335K | ﹤0.01% | 678 |
|
|
2024
Q3 | $1.38M | Sell |
11,965
-2,697
| -18% | -$311K | ﹤0.01% | 712 |
|
|
2024
Q2 | $2.02M | Buy |
+14,662
| New | +$2.02M | ﹤0.01% | 688 |
|
|
2021
Q1 | – | Sell |
-135
| Closed | -$13K | – | 1053 |
|
|
2020
Q4 | $13K | Buy |
+135
| New | +$13K | ﹤0.01% | 805 |
|
|
2020
Q1 | – | Sell |
-53
| Closed | -$6K | – | 931 |
|
|
2019
Q4 | $6K | Buy |
+53
| New | +$6K | ﹤0.01% | 767 |
|